Chromocell Hits Stock Markets Following $6.6M IPO

By Jade Martinez-Pogue · February 16, 2024, 5:09 PM EST

Clinical-stage biotechnology company Chromocell Therapeutics Corp. began trading publicly on Friday after raising $6.6 million in its initial public offering, becoming the latest in a flurry of biotech IPOs....

To view the full article, register now.